Tag «COVID-19»

2-Deoxy-D-glucose

2-Deoxy-D-glucose Molecular FormulaC6H12O5 Average mass164.156 Da 2-Deoxy-D-glucose (4R,5S,6R)-6-(Hydroxymethyl)tetrahydro-2H-pyran-2,4,5-triol (4R,5S,6R)-6-(Hydroxyméthyl)tétrahydro-2H-pyran-2,4,5-triol 154-17-6 [RN] 2-Deoxy-D-arabino-hexopyranose 2-deoxy-D-glucopyranose 2-deoxyglucose 2-DG D-arabino-2-Desoxyhexose D-arabino-Hexopyranose, 2-deoxy- [ (4R,5S,6R)-6-(Hydroxymethyl)oxane-2,4,5-triol 2-deoxyglucopyranose 2-deoxymannopyranose 2-dGlc 61-58-5 [RN] 77252-38-1 [RN] D-arabino-2-Deoxyhexose glucitol, 2,5-anhydro- 2-Deoxy-D-arabino-hexose 2 DG 2-Deoxy-D-glucose 2-Deoxy-D-mannose 2-Deoxyglucose 2-Desoxy-D-glucose Ba 2758 D-Glucose, 2-deoxy- NSC 15193 2-Deoxy-D-glucose CAS Registry Number: 154-17-6 CAS Name: 2-Deoxy-D-arabino-hexose Additional Names: D-arabino-2-desoxyhexose; 2-deoxyglucose; 2-DG Manufacturers’ Codes: Ba-2758 Molecular Formula: C6H12O5 Molecular Weight: 164.16 …

Ramatroban

Ramatroban Formula C21H21FN2O4S CAS 116649-85-5 Mol weight 416.4658 (3R)-3-[[(4-Fluorophenyl)sulfonyl]amino]-1,2,3,4-tetrahydro-9H-carbazole-9-propanoic acid (+)-(3R)-3-(p-fluorobenzenesulfonamido)-1,2,3,4-tetrahydrocarbazole-9-propionic acid; (+)-3-(4-fluorophenylsulfonamido)-9-(2-carboxyethyl)-1,2,3,4-tetrahydrocarbazole 3-[(3R)-3-[(4-fluorophenyl)sulfonylamino]-1,2,3,4-tetrahydrocarbazol-9-yl]propanoic acid Manufacturers’ Codes: Bay u 3405 3-(4-fluorophenylsulfonamido)-1,2,3,4-tetrahydro-9-carbazole propanoic acid BAY u 3405 BAY u 3406 BAY u-3405 BAY u3405 ramatroban Trademarks: Baynas (Bayer) MF: C21H21FN2O4S MW: 416.47 Percent Composition: C 60.56%, H 5.08%, F 4.56%, N 6.73%, O 15.37%, …

Pegylated Interferon alpha-2b, (PegIFN), Virafin

DB00022 sequence CDLPQTHSLGSRRTLMLLAQMRRISLFSCLKDRHDFGFPQEEFGNQFQKAETIPVLHEMI QQIFNLFSTKDSSAAWDETLLDKFYTELYQQLNDLEACVIQGVGVTETPLMKEDSILAVR KYFQRITLYLKEKKYSPCAWEVVRAEIMRSFSLSTNLQESLRSKE CDLPQTHSLG SRRTLMLLAQ MRRISLFSCL KDRHDFGFPQ EEFGNQFQKA ETIPVLHEMI QQIFNLFSTK DSSAAWDETL LDKFYTELYQ QLNDLEACVI QGVGVTETPL MKEDSILAVR KYFQRITLYL KEKKYSPCAW EVVRAEIMRS FSLSTNLQES LRSKE Chemical structure of peginterferon α-2a and α-2b. Abbreviations: PeG-IFN, peginterferon; IFN, interferon; Lys, lysine; His, histidine; Cys, cysteine; Ser, serine. Pegylated Interferon alpha-2b (PegIFN), Virafin Formula C860H1353N229O255S9 CAS 99210-65-8, 98530-12-2, 215647-85-1 Mol weight …

PF-07321332, Nirmatrelvir

PF-07321332, nirmatrelvir UNII-7R9A5P7H32, 7R9A5P7H32, PF07321332 CAS 2628280-40-8, C23H32F3N5O4, 499.5 (1R,2S,5S)-N-[(1S)-1-cyano-2-[(3S)-2-oxopyrrolidin-3-yl]ethyl]-3-[(2S)-3,3-dimethyl-2-[(2,2,2-trifluoroacetyl)amino]butanoyl]-6,6-dimethyl-3-azabicyclo[3.1.0]hexane-2-carboxamide Paxlovid (1R,2S,5S)-N-((1S)-1-Cyano-2-((3S)-2-oxopyrrolidin-3-yl)ethyl)-6,6-dimethyl-3-(3-methyl-N-(trifluoroacetyl)-L-valyl)-3-azabicyclo(3.1.0)hexane-2-carboxamide https://clinicaltrials.gov/ct2/show/NCT04756531 join me on Linkedin Anthony Melvin Crasto Ph.D – India | LinkedIn join me on Researchgate RESEARCHGATE join me on Facebook Anthony Melvin Crasto Dr. | Facebook Twitter FACEBOOK join me on twitter Anthony Melvin Crasto Dr. | twitter +919321316780 call whatsaapp EMAIL. amcrasto@amcrasto ///////////////////////////////////////////////////////////////////////////// SYN https://pubmed.ncbi.nlm.nih.gov/34726479/ https://www.science.org/doi/10.1126/science.abl4784 Science. 2021 Dec 24;374(6575):1586-1593. doi: …

Sinovac COVID-19 vaccine, CoronaVac,

Sinovac COVID-19 vaccine, CoronaVac, PiCoVacc CoronaVac, also known as the Sinovac COVID-19 vaccine,[1] is an inactivated virus COVID-19 vaccine developed by the Chinese company Sinovac Biotech.[2] It has been in Phase III clinical trials in Brazil,[3] Chile,[4] Indonesia,[5] the Philippines,[6] and Turkey.[7] It relies on traditional technology similar to BBIBP-CorV and BBV152, other inactivated-virus COVID-19 vaccines in Phase III trials.[8] CoronaVac does not need to be frozen, and both the vaccine and raw material for …

Sputnik V, Gam-COVID-Vac, Gamaleya

Sputnik V Gam-COVID-Vac Gamaleya SARS-CoV-2 Gam-COVID-Vac Lyo Gam-COVID-Vac was created by Gamaleya Research Institute of Epidemiology and MIcrobiology in Russia. The vaccine candidate is a heterologous COVID-19 vaccine containing two components, recombinant adenovirus type 26 (rAd26) vector and recombinant adenovirus type 5 (rAd5) vector which both carry the SARS-CoV-2 spike glycoprotein. The vaccine is …

Johnson & Johnson COVID-19 vaccine, JNJ 78436735

Johnson & Johnson COVID-19 vaccine, JNJ 78436735 Ad26.COV2.S JNJ-78436735 Ad26COVS1 VAC31518 UNII: JT2NS6183B https://www.onesourcedocs.com/wp-content/uploads/2021/03/Janssen_Pharmaceuticals_SDS_Ad26COVS1_100000015774_v3_5_202102_nr-1.pdf NAME DOSAGE STRENGTH ROUTE LABELLER MARKETING START MARKETING END Covid-19 Vaccine Janssen Injection, suspension 0.95 Inf. U Intramuscular Janssen Cilag International Nv 2021-03-17 Not applicable Janssen COVID-19 Vaccine Injection, suspension 50000000000 {VP}/0.5mL Intramuscular Janssen Products, LP 2021-01-04 Not applicable NAME INGREDIENTS …

NOVAWAX, NVX-CoV2373,

NOVAWAX NVX-CoV2373 SARS-CoV-2 rS Nanoparticle Vaccine MCDC OTA agreement number W15QKN-16-9-1002 Novavax COVID-19 vaccine, Coronavirus disease 19 infection SARS-CoV-2 rS, TAK 019 Novavax, Inc. is an American vaccine development company headquartered in Gaithersburg, Maryland, with additional facilities in Rockville, Maryland and Uppsala, Sweden. As of 2020, it had an ongoing Phase III clinical trial in older adults for its candidate vaccine for seasonal influenza, NanoFlu and a candidate vaccine (NVX-CoV2373) …

BBIBP-CorV, Sinopharm COVID-19 vaccine

BBIBP-CorV, Sinopharm COVID-19 vaccine CAS Number 2503126-65-4 Inactivated novel coronavirus (2019-CoV) vaccine (Vero cells) Purified inactivated SARS-CoV-2 Vaccine ref Lancet Infectious Diseases (2021), 21(1), 39-51. BBIBP-CorV, also known as the Sinopharm COVID-19 vaccine,[1] is one of two inactivated virus COVID-19 vaccines developed by Sinopharm. In late December 2020, it was in Phase III trials in Argentina, Bahrain, Egypt, Morocco, Pakistan, Peru, and the United Arab Emirates (UAE) with over 60,000 participants.[2] On December 9, the …

Moderna COVID-19 vaccine, mRNA 1273

Moderna COVID-19 vaccine, mRNA 1273 CAS 2457298-05-2 An mRNA vaccine against SARS-CoV-2 expressing the prefusion-stabilized SARS-CoV-2 spike trimer MRNA-1273 SARS-COV-2 CX 024414 CX-024414 CX024414 mRNA-1273 NAME DOSAGE STRENGTH ROUTE LABELLER MARKETING START MARKETING END Covid-19 Vaccine Moderna Injection Intramuscular Moderna Therapeutics Inc 2020-12-23 Not applicable Moderna COVID-19 Vaccine Injection, suspension 0.2 mg/1mL Intramuscular Moderna US, Inc. …